This is very simple and understandable IMHO. The RAs told NWBO that you have to have some certified volume manufacturing capabilities before approval. In the USA alone there will be about 13,000 new GBM cases per year. Roughly double that when we include Europe too. How could any RA make DCVAX the new SOC as will soon happen and not have some ability to fulfill the demand.